Literature DB >> 12034452

Mutational analysis of Plasmodium falciparum dihydrofolate reductase: the role of aspartate 54 and phenylalanine 223 on catalytic activity and antifolate binding.

Worachart Sirawaraporn1, Rachada Sirawaraporn, Suganya Yongkiettrakul, Amornpol Anuwatwora, Guilio Rastelli, Sumalee Kamchonwongpaisan, Yongyuth Yuthavong.   

Abstract

The catalytic activity and ability to confer resistance to antifolates of Plasmodium falciparum dihydrofolate reductase (pfDHFR) through single and double mutations at Asp-54 and Phe-223 were investigated. A single Asp54Glu (D54E) mutation in the pfDHFR domain greatly decreased the catalytic activity of the enzyme and affected both the K(m) values for the substrate dihydrofolate and the K(i) values for pyrimethamine, cycloguanil and WR99210. The Phe223Ser (F223S) single mutant had unperturbed kinetics but had very poor affinity with the first two antifolates. The ability to confer high resistance to the antifolates of F223S enzyme was, however, abolished in the D54E+F223S double mutant enzyme. When D54E mutation was present together with the A16V+S108T double mutation, the effects on the K(m) values for the substrate dihydrofolate and the binding affinity of antifolates were much more pronounced. The severely impaired kinetics and poor activity observed in A16V+S108T+D54E enzyme could, however, be restored when F223S was introduced, while the binding affinities to the antifolates remained poor. The experimental findings can be explained with a model for substrate and inhibitor binding. Our data not only indicate the importance of Asp-54 of pfDHFR in catalysis and inhibitor binding, but also provide evidence that infer the potentially crucial function of the C-terminal portion of pfDHFR domain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034452     DOI: 10.1016/s0166-6851(02)00035-x

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  8 in total

1.  Preclinical evaluation of the antifolate QN254, 5-chloro- N'6'-(2,5-dimethoxy-benzyl)-quinazoline-2,4,6-triamine, as an antimalarial drug candidate.

Authors:  Alexis Nzila; Matthias Rottmann; Penchit Chitnumsub; Stevens M Kiara; Sumalee Kamchonwongpaisan; Cherdsak Maneeruttanarungroj; Supannee Taweechai; Bryan K S Yeung; Anne Goh; Suresh B Lakshminarayana; Bin Zou; Josephine Wong; Ngai Ling Ma; Margaret Weaver; Thomas H Keller; Veronique Dartois; Sergio Wittlin; Reto Brun; Yongyuth Yuthavong; Thierry T Diagana
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

2.  Genetic variations of the dihydrofolate reductase gene of Plasmodium vivax in Mandalay Division, Myanmar.

Authors:  Byoung-Kuk Na; Hyeong-Woo Lee; Sung-Ung Moon; Tae-Suk In; Khin Lin; Maung Maung; Gyung-Tae Chung; Jong-Koo Lee; Tong-Soo Kim; Yoon Kong
Journal:  Parasitol Res       Date:  2005-05-28       Impact factor: 2.289

3.  Combined spatial limitation around residues 16 and 108 of Plasmodium falciparum dihydrofolate reductase explains resistance to cycloguanil.

Authors:  Jarunee Vanichtanankul; Supannee Taweechai; Chayasith Uttamapinant; Penchit Chitnumsub; Tirayut Vilaivan; Yongyuth Yuthavong; Sumalee Kamchonwongpaisan
Journal:  Antimicrob Agents Chemother       Date:  2012-04-23       Impact factor: 5.191

4.  Decreased Susceptibility to Dihydrofolate Reductase Inhibitors Associated With Genetic Polymorphisms in Ugandan Plasmodium falciparum Isolates.

Authors:  Oriana Kreutzfeld; Patrick K Tumwebaze; Oswald Byaruhanga; Thomas Katairo; Martin Okitwi; Stephen Orena; Stephanie A Rasmussen; Jennifer Legac; Melissa D Conrad; Sam L Nsobya; Ozkan Aydemir; Jeffrey A Bailey; Maelle Duffey; Roland A Cooper; Philip J Rosenthal
Journal:  J Infect Dis       Date:  2022-02-15       Impact factor: 7.759

5.  Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.

Authors:  Deanpen Japrung; Ubolsree Leartsakulpanich; Sudsanguan Chusacultanachai; Yongyuth Yuthavong
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

6.  Computational analysis of binding between malarial dihydrofolate reductases and anti-folates.

Authors:  Kiattawee Choowongkomon; Sasikrit Theppabutr; Napat Songtawee; Nicholas P J Day; Nicholas J White; Charles J Woodrow; Mallika Imwong
Journal:  Malar J       Date:  2010-03-02       Impact factor: 2.979

7.  Analysis of the dihydrofolate reductase-thymidylate synthase gene sequences in Plasmodium vivax field isolates that failed chloroquine treatment.

Authors:  Won-Ja Lee; Hyung-Hwan Kim; Yien-Kyoung Choi; Kyung-Mi Choi; Mi-A Kim; Jung-Yeon Kim; Jetsumon Sattabongkot; Youngjoo Sohn; Hyuck Kim; Jong-Koo Lee; Han-Sook Park; Hyeong-Woo Lee
Journal:  Malar J       Date:  2010-11-18       Impact factor: 2.979

Review 8.  Driving antimalarial design through understanding of target mechanism.

Authors:  Petar P S Calic; Mahta Mansouri; Peter J Scammells; Sheena McGowan
Journal:  Biochem Soc Trans       Date:  2020-10-30       Impact factor: 5.407

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.